MedTrace Logo

Evaluating a Workbook to Promote Autistic Wellbeing

NCT07630376 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2026-06-05

No results posted yet for this study

Summary

The goal of this clinical trial is to examine the feasibility and acceptability of a brief guided self-help wellbeing intervention for autistic adults accessing UK secondary mental health services. The study also aims to begin to evaluate whether use of the workbook is associated with any changes in wellbeing. The main questions it aims to answer are:

1. Is it feasible to recruit and retain autistic adults to participate in the study?
2. Do participants find the workbook acceptable and relevant?
3. Are there measurable improvements in wellbeing following workbook use?
4. What changes, if any, do participants recommend for future versions of the intervention?

Participants will:

* Take part in 4-6 sessions of 30-60 minutes using the guided self-help workbook with the support of a trained National Health Service support worker, assistant psychologist, or mental health professional
* Complete wellbeing questionnaires before, during, and after using the workbook
* Complete brief daily wellbeing ratings throughout the study
* Take part in a 1:1 semi-structured interview of up to an hour to discuss their experience of the workbook

Conditions

Interventions

BEHAVIORAL

Guided self-help workbook for autistic adults

The workbook's components are: psycho-education and energy accounting (Toudal \& Attwood, 2024) - including sensory awareness - and planning for wellbeing. It will be delivered over four to six sessions of between 30-60 minutes each with a trained National Health Service support worker, assistant psychologist, or mental health professional. Sessions would be conducted in-person, via telephone, or via video.

Sponsors & Collaborators

  • Canterbury Christ Church University

    lead OTHER

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-30
Primary Completion
2027-03-31
Completion
2027-04-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07630376 on ClinicalTrials.gov